Adapting the FACETS Program to Sickle Cell Disease
Recruiting · NCT06650813 · Interventional (participants receive a specific treatment) · Lead sponsor: Versailles Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Drépa-FACETS Program
What this trial is about
Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Participant having freely given his oral agreement.
- Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).
- Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.
Exclusion criteria
- Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints.
- Participants with another chronic pathology causing fatigue.
- Participants in vaso-occlusive crisis (VOC) or hospitalization.
- Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).
Where it is running
2 locations listed.
- CHU Grenoble Alpes - Grenoble, France
- Hospital Versailles - Le Chesnay, France